Keywords: biogen, raises, forecast, shares, up, news, usa-based
Biogen raises forecast, shares up on news
Article | 21 April 2003
USA-based Biogen has raised its earnings forecast for 2003 on the backof stronger-than-expected sales of its top-selling multiple sclerosis drug Avonex ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
